amphetamine has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agari, T; Date, I; Kadota, T; Kameda, M; Kikuchi, Y; Liang, H; Shinko, A; Thomas Tayra, J; Vcelar, B; Wakamori, T; Wang, F; Weik, R; Yasuhara, T | 1 |
| Bolasco, P; Caria, S; Dioguardi, FS; Loria, G; Murtas, S; Secci, R | 1 |
2 other study(ies) available for amphetamine and losartan potassium
| Article | Year |
|---|---|
The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Drug Administration Schedule; Erythropoietin; Female; Hematocrit; Hemoglobins; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Rotarod Performance Test; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Morbid obesity in a young woman affected by advanced chronic kidney disease: an exceptional case report. Does a high dose of essential amino acids play a key role in therapeutic success?
Topics: Adult; Amino Acids, Essential; Amphetamine; Anemia; Body Mass Index; C-Reactive Protein; Diet, Protein-Restricted; Dietary Supplements; Energy Intake; Erythropoietin; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Obesity, Morbid; Patient Compliance; Proteinuria; Quality of Life; Renal Insufficiency, Chronic; Serum Albumin; Treatment Outcome; Waist Circumference | 2016 |